Patent details
EP3510034 Title: SUBSTITUTED IMIDAZO-QUINOLINES AS NLRP3 MODULATORS
Basic Information
- Publication number:
- EP3510034
- PCT Application Number:
- US2018018484
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP187076120
- PCT Publication Number:
- WO2018152396
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SUBSTITUTED IMIDAZO-QUINOLINES AS NLRP3 MODULATORS
- French Title of Invention:
- IMIDAZO-QUINOLÉINES SUBSTITUÉES UTILISÉES EN TANT QUE MODULATEURS DE NLRP3
- German Title of Invention:
- SUBSTITUIERTE IMIDAZO-CHINOLINE ALS NLRP3-MODULATOREN
- SPC Number:
Dates
- Filing date:
- 16/02/2018
- Grant date:
- 22/04/2020
- EP Publication Date:
- 17/07/2019
- PCT Publication Date:
- 23/08/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 22/04/2020
- EP B1 Publication Date:
- 22/04/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 16/02/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 15/04/2020
- Name:
- Innate Tumor Immunity, Inc.
- Address:
- Route 206 and Province Line Road, Princeton, New Jersey 08543, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 09/06/2020
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Inventor
1
- Name:
- GLICK, Gary
- Address:
- United States (US)
2
- Name:
- GHOSH, Shomir
- Address:
- United States (US)
3
- Name:
- OLHAVA, Edward James
- Address:
- United States (US)
4
- Name:
- ROUSH, William R.
- Address:
- United States (US)
5
- Name:
- O'MALLEY, Daniel
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201762460677 P
- Priority Date:
- 17/02/2017
- Priority Country:
- United States (US)
2
- Priority Number:
- 201762490881 P
- Priority Date:
- 27/04/2017
- Priority Country:
- United States (US)
3
- Priority Number:
- 201762573991 P
- Priority Date:
- 18/10/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/437; A61P 35/00; A61P 37/00; C07D 471/04;
Publication
European Patent Bulletin
1
- Issue number:
- 202017
- Publication date:
- 22/04/2020
- Description:
- Grant (B1)
2
- Issue number:
- 202021
- Publication date:
- 20/05/2020
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 31/08/2026
- Annual Fee Number:
- 9
- Annual Fee Amount:
- 115 Euro
- Penalty Fee Amount:
- 20 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 17/02/2025
- Last Annual Fee Paid Number:
- 8
- Last Annual Fee Paid Amount:
- 99 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 10/06/2020 | Outgoing Correspondence | 1 |
| 12/08/2022 | Request For Change | 1 |
| 02/09/2022 | Outgoing Correspondence | 56 |
| 09/06/2020 | Power Of Attorney | 1 |